EZH1/2 alteration as a potential biomarker for immune checkpoint inhibitors across multiple cancer types
oleh: Huageng Huang, Xinyi Deng, Le Yu, He Huang, Zhao Wang, Huangming Hong, Tongyu Lin
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2023-12-01 |
Deskripsi
No description available for this item.